Corentec Co., Ltd. announced that it expects to receive KRW 19.39 billion in funding from Pureun Partners Asset Management, Sun Healthcare International Corp., Misan Corporation, and other investors
November 02, 2020
Share
Corentec Co., Ltd. (KOSDAQ:A104540) announced a private placement of 8th registered unsecured unguaranteed private convertible bonds for proceeds of KRW 15,000,000,000 and 500,000 common shares at an issue price of 8,780 per share for proceeds of 4,390,000,000 for an aggregate proceeds of KRW 19,390,000,000 on November 3, 2020. The bonds will not bear any interest and will have a yield to maturity of 0%. The bonds will mature on December 4, 2025. The bonds will be convertible into common shares at a fixed conversion price of KRW 8,900 per share between December 4, 2021 and November 4, 2025. The company will raise funding through third party allotment. The shares issued in the transaction will be subject to hold period of one year. The transaction has been approved by the board of the company. The payment date is December 4, 2020. The transaction will include participation from Pureun Partners Asset Management for KRW 15,000,000,000, individual investors Sungyi Jung for 227,790 shares, Sun Healthcare International Corp for 113,895 shares, Misan Corporation for 34,168 shares, individual investors Junghee Sun, Changsoo Kim, Han dongam each for 3,416 shares, Jeongah Sun, Sara Suhyun Park, Lee, Gyu-eun, Son, Young-sun, Ryu, Dae-gil, Yang, Sungwon, Hyeyoung Ahn, Shin, Gwangseong, Kim, Chang-sik, Hyungmin Jeon, Hyojin Kim, Hong Seung, Park, Kyungho, Kim, Eon-kyung each for 5,694 shares, Cho, Minsik for 22,779 shares and Jinhong Lee for 11,389 shares.
Corentec Co., Ltd. is a Korea-based company engaged in the development, manufacture and sale of orthopedic implants. The Companyâs products consist of hip products, including primary systems, hemi-arthroplasty systems and revision systems, such as cementless femoral stems, cemented femoral stems, cups for acetabular systems, bearing systems and others; knee products, including primary knee system fixed type, primary knee system mobile type, revision knee systems and augments systems, and spine products, including pedicle screws and peek cages. The Company mainly provides its hip products under the brand name of BENCOX, knee products under the brand name of LOSPA and spine products under the brand name of LOSPA IS. The Company distributes its products within domestic market and to overseas markets.
Corentec Co., Ltd. announced that it expects to receive KRW 19.39 billion in funding from Pureun Partners Asset Management, Sun Healthcare International Corp., Misan Corporation, and other investors
CORENTEC CO., LTD. 
